Cargando…

Adalimumab in the management of Behçet’s disease

Behçet’s disease (BD) is a relapsing, systemic, inflammatory disorder that affects various organ systems. Most of the manifestations of BD are self-limiting, but ocular attacks are an exception. Gastrointestinal tract, central nervous system, and cardiovascular system manifestations are relatively i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ueda, Atsuhisa, Takeno, Mitsuhiro, Ishigatsubo, Yoshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403514/ https://www.ncbi.nlm.nih.gov/pubmed/25926738 http://dx.doi.org/10.2147/TCRM.S56163

Ejemplares similares

Recommendations for the Management of Neuro-Behçet's Disease by the Japanese National Research Committee for Behçet's Disease
por: Hirohata, Shunsei, et al.
Publicado: (2020)

Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease
por: Kirino, Yohei, et al.
Publicado: (2008)

Clinical characteristics of neuro-Behcet’s disease in Japan: a multicenter retrospective analysis
por: Hirohata, Shunsei, et al.
Publicado: (2011)

Functional analysis of macrophages in Behçet's disease
por: Nakano, H, et al.
Publicado: (2015)

Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: use in the differential diagnosis of hyperferritinemia
por: Kirino, Yohei, et al.
Publicado: (2005)

Power Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab—preliminary data
por: Hama, Maasa, et al.
Publicado: (2011)

Armadillo Repeat Containing 8α Binds to HRS and Promotes HRS Interaction with Ubiquitinated Proteins
por: Tomaru, Koji, et al.
Publicado: (2010)

Clinical Course before and after Cataract and Glaucoma Surgery under Systemic Infliximab Therapy in Patients with Behçet's Disease
por: Nishida, Tomomi, et al.
Publicado: (2011)

Continuous evolution of clinical phenotype in 578 Japanese patients with Behçet’s disease: a retrospective observational study
por: Kirino, Yohei, et al.
Publicado: (2016)

Clinical and Pathological Roles of Ro/SSA Autoantibody System
por: Yoshimi, Ryusuke, et al.
Publicado: (2012)

Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis
por: Ishigatsubo, Y, et al.
Publicado: (2015)

Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
por: Hiyama, Tomona, et al.
Publicado: (2019)

Immune Reactions in Behçet's Disease
por: Kaneko, Fumio, et al.
Publicado: (2014)

Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet’s disease in Japan
por: Soejima, Yutaro, et al.
Publicado: (2021)

Pulmonary Sarcoidosis in Behçet’s Disease Treated with Adalimumab
por: Louro, Marlene, et al.
Publicado: (2017)

Distinct clinical features between acute and chronic progressive parenchymal neuro-Behçet disease: meta-analysis
por: Ishido, Mizuho, et al.
Publicado: (2017)

Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1
por: Kirino, Yohei, et al.
Publicado: (2013)

The association of Behçet's syndrome with HLA-B51 as understood in 2021
por: Takeno, Mitsuhiro
Publicado: (2022)

Effect of adiponectin-encoding gene ADIPOQ single nucleotide polymorphisms +45 and +276 on serum lipid levels after antiretroviral therapy in Japanese patients with HIV-1-infection
por: Kato, Hideaki, et al.
Publicado: (2016)

Statins reduce all-cause mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis of observational studies
por: Horita, Nobuyuki, et al.
Publicado: (2014)

Salmonella enterica serovar Ohio septic arthritis and bone abscess in an immunocompetent patient: a case report
por: Kato, Hideaki, et al.
Publicado: (2012)

Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease
por: Kaji, Mariko, et al.
Publicado: (2015)

Adalimumab in Treatment of Uveitis in Pediatric Behcet’s Disease–a Case Report
por: Halilbasic, Meliha, et al.
Publicado: (2021)

The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet’s Retinal Vasculitis
por: Yang, Shizhao, et al.
Publicado: (2021)

Behçet's disease-induced massive small intestinal bleeding successfully treated with adalimumab
por: Liu, PH, et al.
Publicado: (2023)

Net Positive Charge of HIV-1 CRF01_AE V3 Sequence Regulates Viral Sensitivity to Humoral Immunity
por: Naganawa, Satoshi, et al.
Publicado: (2008)

Long-Term Efficacy of Adalimumab in Patients With Intestinal Behcet’s Disease: Eight Consecutive Cases
por: Tanida, Satoshi, et al.
Publicado: (2016)

Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
por: Park, Jihye, et al.
Publicado: (2017)

Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab
por: Ono, Takashi, et al.
Publicado: (2020)

PW03-013 - Behçet's disease: genotype-phenotype correlations
por: Takeuchi, M, et al.
Publicado: (2013)

Usefulness of Adalimumab for Treating a Case of Intestinal Behçet's Disease With Trisomy 8 Myelodysplastic Syndrome
por: Kimura, Masamichi, et al.
Publicado: (2015)

Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet’s disease-related uveitis
por: Ho, Mary, et al.
Publicado: (2019)

Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome
por: Sota, Jurgen, et al.
Publicado: (2021)

Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behçet’s disease susceptibility
por: Takeuchi, Masaki, et al.
Publicado: (2017)

Management of Crohn’s disease in poor responders to adalimumab
por: de Boer, Nanne KH, et al.
Publicado: (2014)

Update on the diagnosis and management of Behçet’s disease
por: Rokutanda, Ryo, et al.
Publicado: (2014)

Behçet's Disease (Adamantiades-Behçet's Disease)
por: Kaneko, Fumio, et al.
Publicado: (2011)

Diagnosis and management of intestinal Behçet’s disease
por: Hisamatsu, Tadakazu, et al.
Publicado: (2014)

Behçet’s Disease in Children: Diagnostic and Management Challenges
por: Costagliola, Giorgio, et al.
Publicado: (2020)

Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study
por: Hibi, Toshifumi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_soe61p9jjjjson3p9prs6nuqto